Skip to main content
Home
FULL MENU Close Menu
Home
Home

HT Staff

News

OMS721 receives orphan designation for use in HSCT

Author:
HT Staff
Publish date: August 30, 2018

The European Commission has granted orphan designation to OMS721 for use in the setting of hematopoietic stem cell transplant (HSCT). OMS721 is a...

  • Read More

News

NICE says CAR T-cell therapy isn’t cost-effective

Author:
HT Staff
Publish date: August 29, 2018

The National Institute for Health and Care Excellence (NICE) has issued a draft guidance recommending against the use of axicabtagene ciloleucel (...

  • Read More

News

Lots of blood collection system recalled

Author:
HT Staff
Publish date: August 29, 2018

The US Food and Drug Administration (FDA) has announced a recall of 10 lots of the Leukotrap RC System with RC2D Filter, a blood collection system...

  • Read More

News

EC approves CAR T-cell therapy for DLBCL, PMBCL

Author:
HT Staff
Publish date: August 28, 2018

The European Commission (EC) has approved the chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel (Yescarta®) to treat two...

  • Read More

News

EC approves product for high-risk AML

Author:
HT Staff
Publish date: August 28, 2018

The European Commission (EC) has approved CPX-351 (Vyxeos), a liposomal formulation that delivers a fixed ratio of daunorubicin and cytarabine (44...

  • Read More

News

FDA grants fast track designation to CX-01 for AML

Author:
HT Staff
Publish date: August 28, 2018

The US Food and Drug Administration (FDA) has granted fast track designation to CX-01 as a treatment for patients older than 60 receiving...

  • Read More

News

EC approves CAR T-cell therapy for ALL, DLBCL

Author:
HT Staff
Publish date: August 27, 2018

The European Commission (EC) has granted approval for tisagenlecleucel (Kymriah®), a chimeric antigen receptor (CAR) T-cell therapy targeting CD19...

  • Read More

News

FDA approves new use for ibrutinib in WM

Author:
HT Staff
Publish date: August 27, 2018

The US Food and Drug Administration (FDA) has approved ibrutinib (Imbruvica®) for use in combination with rituximab to treat adults with...

  • Read More

News

Rivaroxaban doesn’t reduce risk of fatal VTE

Author:
HT Staff
Publish date: August 27, 2018

MUNICH—Extended thromboprophylaxis with rivaroxaban does not significantly reduce the risk of fatal venous thromboembolism (VTE) in patients...

  • Read More

News

Regimen appears effective in elderly, unfit MDS/AML

Author:
HT Staff
Publish date: August 25, 2018

A low-intensity regimen could be an effective treatment option for elderly or unfit patients with newly diagnosed acute myeloid leukemia (AML) or...

  • Read More

News

Study reveals ‘complete mental health’ among cancer survivors

Author:
HT Staff
Publish date: August 24, 2018

New research suggests cancer survivors are just as likely as people without a history of cancer to have complete mental health (CMH), which is...

  • Read More

News

Drug receives priority review for second MM indication

Author:
HT Staff
Publish date: August 24, 2018

The US Food and Drug Administration (FDA) has accepted for priority review a supplemental biologics license application (sBLA) for elotuzumab (...

  • Read More

News

D-dimer and WCP can render VDUs unnecessary

Author:
HT Staff
Publish date: August 23, 2018

Venous duplex ultrasounds (VDUs) may be over-utilized in patients suspected of having deep vein thrombosis (DVT), according to research published...

  • Read More

News

Enzymes convert blood from type A to O more efficiently

Author:
HT Staff
Publish date: August 23, 2018

BOSTON—New research suggests enzymes from the human gut can turn type A blood into type O more efficiently than previously studied enzymes....

  • Read More

News

AMP publishes report on DNA variants in CMNs

Author:
HT Staff
Publish date: August 23, 2018

A new report addresses the clinical relevance of DNA variants in chronic myeloid neoplasms (CMNs). The report is intended to aid clinical...

  • Read More

Pages

  • « first
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close